FDA Approves Bivalent COVID Shots for Kids as Young as 6 Months Old

Published on December 8, 2022

Parents rejoice as the FDA gives the green light for COVID-19 shots from Moderna and Pfizer-BioNTech to be administered to children as young as 6 months. These vaccines are specially designed to target both the original coronavirus and the omicron subvariants, providing broad protection against the evolving virus. This exciting development ensures that even our tiniest humans can get an extra layer of defense against COVID! The approval by the U.S. health regulator is a major milestone in our fight against the pandemic, expanding vaccine availability to a younger age group. With more children eligible for vaccination, we can further reduce the transmission of the virus and protect our little ones from severe illness. It’s important to note that these vaccines have undergone rigorous testing to ensure safety and efficacy in young children. If you have a child who is eligible, consult with your pediatrician to learn more about getting them vaccinated. Together, we can keep our kids safe and contribute to ending this challenging chapter in our history!

The U.S. health regulator has authorized COVID-19 shots from Moderna and Pfizer and its partner BioNTech that target both the original coronavirus and omicron subvariants for use in children as young as 6 months of age. The amended authorization on Thursday from the Food and…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>